The FDA issued a proposed guidance laying out a tentative regulatory pathway for companion diagnostics. The agency also issued a draft guidance on mobile medical apps.

The Centers for Medicare & Medicaid Services is taking the first steps to develop a national benchmark that states can use to set prescription drug reimbursement.